{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-010594","form_type":"8-K","ticker":"DARE","cik":"0001401914","company_name":"Dare Bioscience, Inc.","filed_at":"2026-03-17T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.993608+00:00","generated_at":"2026-05-15T10:19:40.499048+00:00","sec_items":["3.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Daré Bioscience closes $215K Regulation A offering of Series A Preferred Stock and warrants","bullets":["Issued 43,050 Investor Units at $5.00/unit; each unit contains one share of Series A Convertible Preferred and two common stock purchase warrants.","Total gross proceeds of approximately $215,250; warrants exercisable for up to 86,100 shares of common stock.","Offering qualified by SEC on January 5, 2026 under Regulation A; terms previously reported in Form 8-K filed January 29, 2026.","Proceeds provide additional working capital for the company's development programs."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-010594","json":"https://secwatch.observer/filing/0001493152-26-010594.json","markdown":"https://secwatch.observer/filing/0001493152-26-010594.md","text":"https://secwatch.observer/filing/0001493152-26-010594.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1401914/000149315226010594/0001493152-26-010594-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1401914/000149315226010594/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T10:19:40.499048+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}